ApoE4, a protein linked to both Alzheimer’s disease, increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels.
With lives and livelihoods on pause due to COVID-19, Cornell’s Institute of Politics and Global Affairs hosted a TeleTown Hall April 8 to explore a potential timeline for treatment.
The physical sciences at Cornell University jumped to No. 9 among institutions worldwide, up from No. 15 last year, according to the Times Higher Education 2015-16 World University Rankings.
Andrew Rosenblatt ’20, student in the lab of Tobias Doerr, assistant professor of microbiology, is working to make cholera less resistant to treatment by a broad range of antibiotics.
New research suggests genetic variation in the most essential component of the ribosome, ribosomal RNA, may influence how much and which proteins are made.
Reducing antibiotic resistance in animals and developing a lubricating formula in joints for people suffering from arthritis are two of seven projects that received Center for Advanced Technology annual grants.
Cornell researchers are working collaboratively at the forefront of their fields to re-examine and adapt their innovations to develop the tests, treatments and knowledge necessary to end the COVID-19 pandemic.
The Atkinson Center for a Sustainable Future is welcoming five new postdoctoral fellows, who will study global food systems, health and energy transitions.